RadNet, Inc.
RadNet, Inc. (RDNT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
rdnt · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for RadNet, Inc. (RDNT) measures how much investors pay for each dollar of the company's trailing earnings. RDNT's current PE ratio of N/A is calculated by dividing its stock price of $54.16 by its TTM earnings per share of -$0.18.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 13 fiscal years · Front-end computedMinQ1 · 25%63.9x
MedianQ3 · 75%8933.9x
Max
At N/A, RDNT's current P/E is lower than in 0% of its annual fiscal year readings over the past 13 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Diagnostics & Research · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
RadNet, Inc.You RDNT | $4.3B | N/A | — | -$0.18 |
 Bausch + Lomb Corporation BLCO | $5.4B | N/A | — | -$1.02 |
 Bruker Corporation BRKR | $8.6B | N/A | — | -$0.06 |
 BrightSpring Health Services, Inc. Common Stock BTSG | $11.5B | 39.79x | +22.0% | $0.94 |
 Chemed Corporation CHE | $5.8B | 23.23x | -28.8% | $18.42 |
 iRhythm Technologies, Inc. IRTC | $3.5B | N/A | — | -$1.39 |
 Krystal Biotech, Inc. KRYS | $8.9B | 34.84x | +6.8% | $7.08 |
Industry Average 3 peers with valid PE | — | 32.62x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.25 | — | |
2024-12-31 FY2024 | 1826.32x | $0.04 | +151.5% | |
2023-12-31 FY2023 | 726.24x | $0.05 | +629.7% | |
2022-12-31 FY2022 | 99.53x | $0.19 | +55.7% | |
2021-12-31 FY2021 | 63.93x | $0.47 | — | |
2020-12-31 FY2020 | — | $-0.29 | — | |
2019-12-31 FY2019 | 68.34x | $0.30 | +350.3% | |
2018-12-31 FY2018 | 15.18x | $0.67 | -99.8% | |
2017-12-31 FY2017 | 8933.88x | $0.00 | +21555.2% | |
2016-12-31 FY2016 | 41.26x | $0.16 | +17.5% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for RadNet, Inc. (RDNT) measures how much investors pay for each dollar of the company's trailing earnings. RDNT's current PE ratio of N/A is calculated by dividing its stock price of $54.16 by its TTM earnings per share of -$0.18.
Frequently asked questions
RDNT pe ratio · 6 questionsRDNT's current PE ratio is N/A as of 2026-06-09, based on a stock price of $54.16 and TTM EPS of -$0.18. Data sourced from Financial Modeling Prep via RDNT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · RadNet, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09